Tracy A Battaglia1, Karen M Freund2, Jennifer S Haas3, Nicole Casanova4, Sharon Bak5, Howard Cabral6, Rachel A Freedman7, Karen Burns White8, Stephenie C Lemon9. 1. Women's Health Unit, Section of General Internal Medicine, Boston University School of Medicine, Boston, MA, United States of America. Electronic address: Tracy.Battaglia@bmc.org. 2. Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, United States of America; Division of Internal Medicine and Primary Care, Department of Medicine, Tufts Medical Center, Boston, MA, United States of America; Tufts University School of Medicine, Boston, MA, United States of America. 3. Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America. 4. Women's Health Unit, Section of General Internal Medicine, Boston University School of Medicine, Boston, MA, United States of America. 5. Women's Health Unit, Section of General Internal Medicine, Boston University School of Medicine, Boston, MA, United States of America; Boston University School of Medicine, Boston, MA, United States of America. 6. Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States of America. 7. Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, United States of America. 8. Initiative to Eliminate Cancer Disparities, Dana Farber/Harvard Cancer Center, Boston, MA, United States of America. 9. Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, MA, United States of America.
Abstract
BACKGROUND: Racial and socioeconomic disparities in breast cancer mortality persist. In Boston, MA, Black, Non-Hispanic women and Medicaid-insured individuals are 2-3 times more likely to have delays in treatment compared to White or privately insured women. While evidence-based care coordination strategies for reducing delays exist, they are not systematically implemented across healthcare settings. METHODS: Translating Research Into Practice (TRIP) utilizes community engaged research methods to address breast cancer care delivery disparities. Four Massachusetts Clinical and Translational Science Institute (CTSI) hubs collaborated with the Boston Breast Cancer Equity Coalition (The Coalition) to implement an evidence-based care coordination intervention for Boston residents at risk for delays in breast cancer care. The Coalition used a community-driven process to define the problem of care delivery disparities, identify the target population, and develop a rigorous pragmatic approach. We chose a cluster-randomized, stepped-wedge hybrid type I effectiveness-implementation study design. The intervention implements three evidence-based strategies: patient navigation services, a shared patient registry for use across academic medical centers, and a web-based social determinants of health platform to identify and address barriers to care. Primary clinical outcomes include time to first treatment and receipt of guideline-concordant treatment, which are captured through electronic health records abstraction. We will use mixed methods to collect the secondary implementation outcomes of acceptability, adoption/penetration, fidelity, sustainability and cost. CONCLUSION: TRIP utilizes an innovative community-driven research strategy, focused on interdisciplinary collaborations, to design and implement a translational science study that aims to more efficiently integrate proven health services interventions into clinical practice.
RCT Entities:
BACKGROUND: Racial and socioeconomic disparities in breast cancer mortality persist. In Boston, MA, Black, Non-Hispanic women and Medicaid-insured individuals are 2-3 times more likely to have delays in treatment compared to White or privately insured women. While evidence-based care coordination strategies for reducing delays exist, they are not systematically implemented across healthcare settings. METHODS: Translating Research Into Practice (TRIP) utilizes community engaged research methods to address breast cancer care delivery disparities. Four Massachusetts Clinical and Translational Science Institute (CTSI) hubs collaborated with the Boston Breast Cancer Equity Coalition (The Coalition) to implement an evidence-based care coordination intervention for Boston residents at risk for delays in breast cancer care. The Coalition used a community-driven process to define the problem of care delivery disparities, identify the target population, and develop a rigorous pragmatic approach. We chose a cluster-randomized, stepped-wedge hybrid type I effectiveness-implementation study design. The intervention implements three evidence-based strategies: patient navigation services, a shared patient registry for use across academic medical centers, and a web-based social determinants of health platform to identify and address barriers to care. Primary clinical outcomes include time to first treatment and receipt of guideline-concordant treatment, which are captured through electronic health records abstraction. We will use mixed methods to collect the secondary implementation outcomes of acceptability, adoption/penetration, fidelity, sustainability and cost. CONCLUSION: TRIP utilizes an innovative community-driven research strategy, focused on interdisciplinary collaborations, to design and implement a translational science study that aims to more efficiently integrate proven health services interventions into clinical practice.
Authors: Eileen T Lake; Douglas Staiger; Jeffrey Horbar; Michael J Kenny; Thelma Patrick; Jeannette A Rogowski Journal: Health Serv Res Date: 2014-09-22 Impact factor: 3.402
Authors: Karen M Freund; Jennifer S Haas; Stephenie C Lemon; Karen Burns White; Nicole Casanova; Laura S Dominici; John K Erban; Rachel A Freedman; Ted A James; Naomi Y Ko; Amy M LeClair; Beverly Moy; Susan K Parsons; Tracy A Battaglia Journal: Cancer Date: 2019-08-26 Impact factor: 6.860
Authors: John M McLaughlin; Roger T Anderson; Amy K Ferketich; Eric E Seiber; Rajesh Balkrishnan; Electra D Paskett Journal: J Clin Oncol Date: 2012-11-19 Impact factor: 44.544
Authors: Ram K Shrestha; Lytt Gardner; Gary Marks; Jason Craw; Faye Malitz; Thomas P Giordano; Meg Sullivan; Jeanne Keruly; Allan Rodriguez; Tracey E Wilson; Michael Mugavero Journal: J Acquir Immune Defic Syndr Date: 2015-03-01 Impact factor: 3.731
Authors: Tracy A Battaglia; Sharon M Bak; Timothy Heeren; Clara A Chen; Richard Kalish; Stephen Tringale; James O Taylor; Barbara Lottero; A Patrick Egan; Nisha Thakrar; Karen M Freund Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-10 Impact factor: 4.254
Authors: Naomi Y Ko; Frederick R Snyder; Peter C Raich; Electra D Paskett; Donald J Dudley; Ji-Hyun Lee; Paul H Levine; Karen M Freund Journal: Cancer Date: 2016-05-26 Impact factor: 6.860
Authors: Amy M LeClair; Tracy A Battaglia; Nicole L Casanova; Jennifer S Haas; Karen M Freund; Beverly Moy; Susan K Parsons; Naomi Y Ko; JoEllen Ross; Ellen Ohrenberger; Katelyn R Mullikin; Stephenie C Lemon Journal: Support Care Cancer Date: 2021-11-12 Impact factor: 3.603
Authors: Nicole L Casanova; Amy M LeClair; Victoria Xiao; Katelyn R Mullikin; Stephenie C Lemon; Karen M Freund; Jennifer S Haas; Rachel A Freedman; Tracy A Battaglia Journal: Cancer Date: 2022-07-01 Impact factor: 6.921
Authors: Stephanie Loo; Katelyn Mullikin; Charlotte Robbins; Victoria Xiao; Tracy A Battaglia; Stephenie C Lemon; Christine Gunn Journal: BMC Health Serv Res Date: 2022-05-21 Impact factor: 2.908
Authors: Cheryl R Clark; Jennifer S Haas; Stephenie C Lemon; Karen M Freund; Karen Burns White; Caylin Marotta; Amy J Wint; Amy M LeClair; Christine Lloyd-Travaglini; Victoria Xiao; Nicole Casanova; Tracy A Battaglia Journal: J Natl Cancer Inst Date: 2021-01-04 Impact factor: 13.506
Authors: Serena Rajabiun; Victoria Xiao; Sharon Bak; Charlotte Robbins; Nicole Casanova; Howard J Cabral; Stephenie C Lemon; Jennifer S Haas; Karen M Freund; Tracy Battaglia Journal: BMC Health Serv Res Date: 2022-07-08 Impact factor: 2.908